All Stories

  1. Blood Culture Negative Endocarditis; What Do Concurrent Cardiac Disorders Tell Us?
  2. Infectious causes of fever of unknown origin in developing countries: An international ID-IRI study
  3. Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID‐19‐associated candidemia
  4. Can daily bathing with 4% chlorhexidine + daily chlorhexidine wipe for 1 week be effective in decolonizing Candida auris colonization?
  5. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
  6. Changing Trends in the Epidemiology of Delta Virus Infection
  7. Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study
  8. Features of Mpox infection: The analysis of the data submitted to the ID-IRI network
  9. The earthquake in Türkiye and infectious disease concerns
  10. Predictive factors and prognostic value of candiduria in critically-ill patients with solid and hematological malignancies
  11. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
  12. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
  13. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey
  14. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
  15. Vaccine hesitancy and refusal among parents: An international ID-IRI survey
  16. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study
  17. Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia
  18. International Multicentre Study of Candida auris Infections
  19. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey
  20. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
  21. Letter to Editor in response to Dr. Gupta
  22. Brucellosis in Patients with Neoplasm; A Research Article
  23. Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website
  24. Anxiety among front-line health-care workers supporting patients with COVID-19: A global survey
  25. The diagnostic utility of the “Thwaites’ system” and “lancet consensus scoring system” in tuberculous vs. non-tuberculous subacute and chronic meningitis: multicenter analysis of 395 adult patients
  26. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
  27. A Statistical Modeling of the Course of COVID-19 (SARS-CoV-2) Outbreak: A Comparative Analysis
  28. Various combinations of Carbapenemase production in community-acquired clinical isolates in Nepal
  29. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study
  30. A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model
  31. Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study
  32. Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal
  33. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module
  34. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study
  35. Portraying infective endocarditis: results of multinational ID-IRI study
  36. Brucellosis in pregnancy: results of multicenter ID-IRI study
  37. Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey
  38. Extrapulmonary Tuberculosis
  39. Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study
  40. Radiological data in microbiologically confirmed central nervous system tuberculosis
  41. Infection Control Bundles in Intensive Care: An International Cross-sectional survey in Low-Middle Income Countries
  42. Correction to: Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study
  43. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study
  44. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis
  45. Managing atypical and typical herpetic central nervous system infections: results of a multinational study – Authors' reply
  46. Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey
  47. “Salvage treatment” for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal
  48. The burden and epidemiology of community-acquired central nervous system infections: a multinational study
  49. Tetanus in adults: results of the multicenter ID-IRI study
  50. Brucellosis
  51. Other Foci of Infections in Community Acquired Central Nervous System Infections
  52. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey
  53. Preface
  54. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C
  55. Managing atypical and typical herpetic central nervous system infections: results of a multinational study
  56. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study
  57. Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study
  58. Management of septic shock and severe infections in migrants and returning travelers requiring critical care
  59. A Rare Case of Brucella Spondylodiscitis Mimicking Lumbar Disc Herniation
  60. Distribution of Tuberculomas and Vasculitic Lesions in Microbiologically Confirmed Central Nervous System Tuberculosis
  61. Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meninigitis: Results of Haydarpasa-III study
  62. Neurosyphilis: Results of a Multicentric Infectious Diseases International Research Initiative (ID-IRI) Study
  63. Assessment of Health-Related Quality of Life in Chronic Hepatitis B Infection Patients in Turkey: A Multicenter Study
  64. Comparison of brucellar and tuberculous spondylodiscitis patients: results of the multicenter “Backbone-1 Study”
  65. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
  66. The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study
  67. Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?
  68. New global viral threats
  69. Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis
  70. Tuberculous and brucellosis meningitis differential diagnosis
  71. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study
  72. A Case of Pneumonia and Bacteriamia Caused by Corynebacterium Striatum in a Immun Supressed Host
  73. Imaging Data in Neurobrucellosis and the Factors Predicting Inflammatory Changes: Results of Istanbul-3 Study
  74. Evaluation of tularaemia courses: a multicentre study from Turkey
  75. Genitourinary brucellosis: results of a multicentric study
  76. The microbiological diagnosis of tuberculous meningitis of Haydarpasa-1 study
  77. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
  78. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients
  79. Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance
  80. Two Imported and Relapsed of Plasmodium vivax Malaria Cases and Primaquine Prophylaxis
  81. Comment to the Letter to the Editor
  82. The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study
  83. Emergence and co-infections of West Nile virus and Toscana virus in Eastern Thrace, Turkey
  84. Detection of Salmonella arizonae in an enteric fever outbreak by the ID 32 GN automated system
  85. The Management of Therapeutic Failure in a Falciparum Malaria Patient under Oral Arthemether-Lumefantrine Therapy
  86. Liver involvement in patients with brucellosis: results of the Marmara study
  87. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study
  88. Mortality indicators in pneumococcal meningitis: therapeutic implications
  89. Update on treatment options for spinal brucellosis
  90. Respiratory System Involvement in Brucellosis
  91. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: a multicentre retrospective study
  92. 1479Evaluation of Tularemia Courses: A Multicenter Study From Turkey
  93. 1160Compliance of rabies post exposure prophylaxis and rabies vaccine application problems
  94. 1477Factors affecting the early clinical response in due course of tuberculous meningitis treatment: Results of Haydarpasa-3 Study
  95. 1475Hamsi scoring in the prediction of unfavorable outcomes in tuberculous meningitis: Results of multinational Haydarpasa-2 Study
  96. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: Risk factors for mortality
  97. Withdrawal of Staphylococcus aureus from intensive care units in Turkey
  98. Arboviral Surveillance of Field-Collected Mosquitoes Reveals Circulation of West Nile Virus Lineage 1 Strains in Eastern Thrace, Turkey
  99. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey
  100. Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients
  101. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study
  102. Leading infectious diseases problems in Turkey
  103. Can chitotriosidase be a surrogate marker for invasive fungal disease?
  104. Management of Brucella endocarditis: results of the Gulhane study
  105. Basic answers to complicated questions for the course of chronic hepatitis C treatment
  106. Can chitotriosidase be a surrogate marker for invasive fungal disease?
  107. The Place and the Efficacy of Infectious Disease Consultations in the Hospitals
  108. Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul Study
  109. War and infection in the pre-antibiotic era: The Third Ottoman Army in 1915
  110. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs
  111. Management of community-acquired acute bacterial cystitis in Turkey
  112. Community-acquired acute bacterial meningitis in the elderly in Turkey
  113. Overview of neurobrucellosis: a pooled analysis of 187 cases
  114. Stress-related Epstein–Barr virus reactivation
  115. Pneumococcal seroepidemiology in Turkey
  116. An Update on Invasive Pneumococcal Antibiotic Resistance in Turkey, 2008
  117. Meningoencephalitis associated with human parvovirus B19
  118. Changes in hepatitis A prevalence rates between 1998 and 2007 in Eskisehir, Turkey
  119. Prevalence of HIV and Syphilis among Turkish Blood Donors
  120. Erratum to “Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage” [Vaccine 26 (10) (2008) 1271–1273]
  121. Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage
  122. Prevalence of HIV and syphilis among Turkish blood donors
  123. Management of Neurobrucellosis: An Assessment of 11 Cases
  124. Management of Neurobrucellosis: An Assessment of 11 Cases
  125. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study
  126. Hydatid cysts in muscle: a modified percutaneous treatment approach
  127. The Usefulness of Endoscopic Retrograde Cholangiopancreatography and 99mTc-Labeled Albumin Macroaggregates in Diagnosing Hydatid Disease Fistulae
  128. A review of the current place of glycopeptides in turkish medical practice
  129. Distribution of hepatitis C virus infection in the male Turkish population
  130. Delayed and misdiagnosis of wrist tuberculosis
  131. Epidemiology of corynebacterial urinary infections
  132. The Effects of Topical Ketorolac and Indomethacin on Measles Conjunctivitis: Randomized Controlled Trial
  133. Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey
  134. Giardiasis in Sivas, Turkey
  135. Saccharomyces boulardiiand infection due toGiardia lamblia
  136. Profiles of biochemical parameters in central nervous system fluid during the therapeutic courses of adult Mycobacterium tuberculosis meningitis
  137. A New Percutaneous Approach for the Treatment of Hydatid Cyst of the Kidney: Long-term Follow-up
  138. Effect of Climate on the Bacteriology of Chronic Suppurative Otitis Media
  139. Treatment of Brucella Endocarditis: Our Surgical Experience with 6 Patients
  140. Prevalence of hepatitis B virus infection in young Turkish men
  141. Therapeutic options for pneumococcal pneumonia in Turkey
  142. Antibiotic Resistance in PathogenicStreptococcus pneumoniaeIsolates in Turkey
  143. Gram-Negative Bacterial Resistance to Cephalosporins in Community-Acquired Infections in Turkey
  144. Bacteriology in Patients with Chronic Sinusitis who have been Medically and Surgically Treated
  145. Identification of yeasts in public hospital primary care patients with or without clinical vaginitis
  146. An Unusual Cause of Vertebral Osteomyelitis: Candida Species